and Manufacturing Organization (CRDMO), today announced that it has again passed the GMP inspection by Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for its drug substance facilities ...

Symbiosis Pharmaceutical Services has completed the latest inspection by the U.S. FDA of its facilities in Scotland.

WUXI, China, Feb. 27, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has ...

WuXi Biologics (WuXi Bio), a leading global contract research, development, and manufacturing organization, announced that it has again passed the GMP inspection by Japan’s Pharmaceuticals and Medical ...